Aktis Oncology, Inc. (AKTS) SEC filings
AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.16−0.46 (-2.77%)
Close on Nov 16, 2026Market cap $898.81MP/E –Yield –
SEC filings
10 of Aktis Oncology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2026 | Nov 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
See a number that looks wrong?